Laboratorios Legrand
Bogotá, Colombia· Est.
Colombian generics manufacturer accelerating access to affordable medicines across Latin America.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Estimated funding: $15M
AI Company Overview
Colombian generics manufacturer accelerating access to affordable medicines across Latin America.
CardiologyInfectious DiseasesOncologyEndocrinology
Technology Platform
Modern solid‑dose and sterile injectable manufacturing combined with in‑house API synthesis and bioequivalence analytics.
Opportunities
Expansion into biosimilar oncology products and broader Latin American export markets.
Risk Factors
Regulatory delays, price competition, and capital intensity of maintaining GMP‑compliant facilities.
Competitive Landscape
Competes with regional generics firms such as Bago Pharma and Almirall; differentiates through rapid manufacturing scalability and a growing biosimilar pipeline.